{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T19:23:36Z","timestamp":1792869816240,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K23AG084883"],"award-info":[{"award-number":["K23AG084883"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG032289"],"award-info":[{"award-number":["R01AG032289"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG072475"],"award-info":[{"award-number":["R01AG072475"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alzheimer\u2019s Association Research Grants","award":["AARF-22-974065"],"award-info":[{"award-number":["AARF-22-974065"]}]},{"name":"Alzheimer\u2019s Association Research Grants","award":["AARF-23-1145318"],"award-info":[{"award-number":["AARF-23-1145318"]}]},{"name":"Alzheimer\u2019s Association Research Grants","award":["AARG-20-683875"],"award-info":[{"award-number":["AARG-20-683875"]}]},{"name":"New Vision Research","award":["CCAD 2024-001-1"],"award-info":[{"award-number":["CCAD 2024-001-1"]}]},{"DOI":"10.13039\/100001167","name":"Larry L. Hillblom Foundation","doi-asserted-by":"publisher","award":["2018-A-006-NET"],"award-info":[{"award-number":["2018-A-006-NET"]}],"id":[{"id":"10.13039\/100001167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001167","name":"Larry L. Hillblom Foundation","doi-asserted-by":"publisher","award":["2024-A-001-CTR"],"award-info":[{"award-number":["2024-A-001-CTR"]}],"id":[{"id":"10.13039\/100001167","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dementia risk is significantly shaped by cardiovascular health, with elevated blood pressure emerging as a key risk factor for adverse brain aging. Blood biomarkers such as pTau181, A\u03b242\/40, NfL, and GFAP have improved our understanding of dementia pathophysiology, however, few studies have explored how specific blood pressure metrics relate to biomarker levels, which could inform personalized dementia prevention strategies as these biomarkers move into clinic. We examined how different blood pressure metrics associated with molecular markers of astrocytic activation (GFAP), neuronal axon breakdown (NfL), and Alzheimer\u2019s disease pathobiology (pTau181, A\u03b242\/40) in plasma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      109 functionally intact (Clinical Dementia Rating Scale\u2009=\u20090) older adults completed blood draws with plasma assayed for A\u03b242\/40, GFAP, NfL, and pTau181 (Quanterix Simoa) and in-lab blood pressure quantification. Blood pressure metrics included diastolic blood pressure, systolic blood pressure, and pulse pressure (systolic minus diastolic). Separate regression models evaluated plasma biomarkers as a function of each blood pressure metric, adjusting for age and biological sex. Interaction models tested whether relationships between blood pressure metrics and plasma biomarkers differed by sex, age, or\n                      <jats:italic>APOE<\/jats:italic>\n                      -\u03b54 status.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      With the exception of A\u03b242\/40, higher pulse pressure related to higher levels of all plasma biomarkers examined (pTau181, NfL, GFAP). Additionally, higher systolic blood pressure related to higher pTau181, while diastolic blood pressure did not meaningfully associate with any biomarker. Interaction models revealed a significantly stronger relationship between elevated pulse pressure and higher GFAP concentrations in females compared to males, as well as a significantly stronger association between elevated pulse pressure and lower A\u03b242\/40 plasma concentrations in\n                      <jats:italic>APOE<\/jats:italic>\n                      -\u03b54 carriers compared to non-carriers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest that elevated pulse pressure, and to a lesser extent systolic blood pressure, are associated with increased Alzheimer\u2019s disease and neurodegenerative (axonal and astrocytic health) biology among typically aging adults. These associations underscore the importance of blood pressure management, particularly pulse pressure, for reducing dementia risk. Cardiovascular health may be incorporated with biomarkers to further personalize dementia prevention and management strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-025-01731-9","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T04:23:31Z","timestamp":1745209411000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Relationships between blood pressure indicators and fluid biomarkers of brain aging in functionally intact older adults"],"prefix":"10.1186","volume":"17","author":[{"given":"Anna M.","family":"VandeBunte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailey L.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily W.","family":"Paolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowan","family":"Saloner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubir","family":"Dutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire J.","family":"Cadwallader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coty","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argentina Lario","family":"Lago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C.","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Sible","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel H.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin B.","family":"Casaletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"1731_CR1","doi-asserted-by":"crossref","unstructured":"The Lancet Public Health. Reinvigorating the public health response to dementia. Lancet Public Health [Internet]. 2021 [cited 2024 Apr 30];6:e696. Available from: http:\/\/www.thelancet.com\/article\/S2468266721002152\/fulltext","DOI":"10.1016\/S2468-2667(21)00215-2"},{"key":"1731_CR2","doi-asserted-by":"publisher","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet Commissions. thelancet.com [Internet]. 2020 [cited 2023 May 23];396:413\u201359. Available from: https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6","DOI":"10.1016\/S0140-6736(20)30367-6"},{"key":"1731_CR3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","volume":"13","author":"S Norton","year":"2014","unstructured":"Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer\u2019s disease: an analysis of population-based data. Lancet Neurol. 2014;13:788\u201394.","journal-title":"Lancet Neurol"},{"key":"1731_CR4","doi-asserted-by":"publisher","first-page":"1095236","DOI":"10.3389\/fepid.2023.1095236","volume":"3","author":"J Brain","year":"2023","unstructured":"Brain J, Greene L, Tang EYH, Louise J, Salter A, Beach S, et al. Cardiovascular disease, associated risk factors, and risk of dementia: an umbrella review of meta-analyses. Front Epidemiol. 2023;3:1095236.","journal-title":"Front Epidemiol"},{"key":"1731_CR5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrcardio.2010.161","volume":"7","author":"V Novak","year":"2010","unstructured":"Novak V, Hajjar I. The relationship between blood pressure and cognitive function. Nat Rev Cardiol. 2010;7:686\u201398.","journal-title":"Nat Rev Cardiol"},{"key":"1731_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","volume":"75","author":"FD Fuchs","year":"2020","unstructured":"Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75:285\u201392.","journal-title":"Hypertension"},{"key":"1731_CR7","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1212\/01.WNL.0000164712.24389.BB","volume":"64","author":"IB Goldstein","year":"2005","unstructured":"Goldstein IB, Bartzokis G, Guthrie D, Shapiro D. Ambulatory blood pressure and the brain. Neurology. 2005;64:1846\u201352.","journal-title":"Neurology"},{"key":"1731_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/archneur.60.2.223","volume":"60","author":"C Qiu","year":"2003","unstructured":"Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L. Low blood pressure and risk of dementia in the kungsholmen project. Arch Neurol. 2003;60:223.","journal-title":"Arch Neurol"},{"key":"1731_CR9","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1097\/HJH.0b013e32836184b5","volume":"31","author":"O Beauchet","year":"2013","unstructured":"Beauchet O, Celle S, Roche F, Bartha R, Montero-Odasso M, Allali G, et al. Blood pressure levels and brain volume reduction. J Hypertens. 2013;31:1502\u201316.","journal-title":"J Hypertens"},{"key":"1731_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00392-016-0972-2","volume":"105","author":"F-D Liu","year":"2016","unstructured":"Liu F-D, Shen X-L, Zhao R, Tao X-X, Wang S, Zhou J-J, et al. Pulse pressure as an independent predictor of stroke: a systematic review and a meta-analysis. Clin Res Cardiol. 2016;105:677\u201386.","journal-title":"Clin Res Cardiol"},{"key":"1731_CR11","doi-asserted-by":"crossref","unstructured":"Hakim A, Ng. Turek. Heart disease as a risk factor for dementia. Clin Epidemiol. 2013;135.","DOI":"10.2147\/CLEP.S30621"},{"key":"1731_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3233\/JAD-191114","volume":"74","author":"KB Casaletto","year":"2020","unstructured":"Casaletto KB, Renter\u00eda MA, Pa J, Tom SE, Harrati A, Armstrong NM, et al. Late-Life physical and cognitive activities independently contribute to brain and cognitive resilience. J Alzheimer\u2019s Disease. 2020;74:363\u201376.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"1731_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3988\/jcn.2022.18.6.619","volume":"18","author":"H-B Kim","year":"2022","unstructured":"Kim H-B, Jung YH, Han HJ. Resting heart rate and cognitive decline: A Meta-Analysis of prospective cohort studies. J Clin Neurol. 2022;18:619.","journal-title":"J Clin Neurol"},{"key":"1731_CR14","doi-asserted-by":"publisher","first-page":"153331752311722","DOI":"10.1177\/15333175231172283","volume":"38","author":"A Mathew","year":"2023","unstructured":"Mathew A, Mesa R, Nahodyl L, Tremblay J, Rundek T, Zeki Al Hazzouri A, et al. Diastolic blood pressure and cognitive functioning: differences by systolic blood pressure among US adults. Am J Alzheimers Dis Other Demen. 2023;38:153331752311722.","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"1731_CR15","doi-asserted-by":"crossref","unstructured":"Tao QQ, Lin RR, Wu ZY. Early Diagnosis of Alzheimer\u2019s Disease: Moving Toward a Blood-Based Biomarkers Era. Clin Interv Aging [Internet]. 2023 [cited 2024 Apr 30];18:353\u20138.Available from: https:\/\/www.dovepress.com\/early-diagnosis-of-alzheimers-disease-moving-toward-a-blood-based-biom-peer-reviewed-fulltext-article-CIA.","DOI":"10.2147\/CIA.S394821"},{"key":"1731_CR16","doi-asserted-by":"crossref","unstructured":"Thomas AJ, Hamilton CA, Heslegrave A, Barker S, Durcan R, Lawley S et al. A Longitudinal Study of Plasma pTau181 in Mild Cognitive Impairment with Lewy Bodies and Alzheimer\u2019s Disease. Movement Disorders [Internet]. 2022 [cited 2024 May 12];37:1495. Available from: \/pmc\/articles\/PMC9540809\/","DOI":"10.1002\/mds.28994"},{"key":"1731_CR17","doi-asserted-by":"crossref","unstructured":"Doecke JD, P\u00e9rez-Grijalba V, Fandos N, Fowler C, Villemagne VL, Masters CL et al. Total A\u03b2 42 \/A\u03b2 40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis. Neurology. 2020;94.","DOI":"10.1212\/WNL.0000000000009240"},{"key":"1731_CR18","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Valle R, Heslegrave A, Foiani MS, Bosch B, Antonell A, Balasa M et al. Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer\u2019s disease. Alzheimers Res Ther [Internet]. 2018 [cited 2024 May 1];10. Available from: \/pmc\/articles\/PMC6215337\/.","DOI":"10.1186\/s13195-018-0439-y"},{"key":"1731_CR19","doi-asserted-by":"crossref","unstructured":"Simonsen AH, Gleerup HS, Musaeus CS, Sellebjerg F, Hansen MB, S\u00f8ndergaard HB et al. Neurofilament light chain levels in serum among a large mixed memory clinic cohort: Confounders and diagnostic usefulness. Alzheimers Dement (Amst) [Internet]. 2023 [cited 2024 May 12];15. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38094990\/","DOI":"10.1002\/dad2.12512"},{"key":"1731_CR20","doi-asserted-by":"crossref","unstructured":"Pereira JB, Janelidze S, Smith R, Mattsson-Carlgren N, Palmqvist S, Teunissen CE et al. Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease. Brain [Internet]. 2021 [cited 2024 May 1];144:3505\u201316. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34259835\/","DOI":"10.1093\/brain\/awab223"},{"key":"1731_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","volume":"18","author":"A Abdelhak","year":"2022","unstructured":"Abdelhak A, Foschi M, Abu-Rumeileh S, Yue JK, D\u2019Anna L, Huss A, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol. 2022;18:158\u201372.","journal-title":"Nat Rev Neurol"},{"key":"1731_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13195-024-01459-y","volume":"16","author":"HE Dark","year":"2024","unstructured":"Dark HE, An Y, Duggan MR, Joynes C, Davatzikos C, Erus G, et al. Alzheimer\u2019s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline. Alzheimers Res Ther. 2024;16:94.","journal-title":"Alzheimers Res Ther"},{"key":"1731_CR23","doi-asserted-by":"publisher","first-page":"100134","DOI":"10.1016\/j.nbas.2024.100134","volume":"7","author":"RA Honea","year":"2025","unstructured":"Honea RA, Wilkins H, Hunt SL, Kueck PJ, Burns JM, Swerdlow RH, et al. TOMM40 May mediate GFAP, neurofilament light protein, pTau181, and brain morphometry in aging. Aging Brain. 2025;7:100134.","journal-title":"Aging Brain"},{"key":"1731_CR24","doi-asserted-by":"publisher","unstructured":"Jiang X, O\u2019Bryant SE, Johnson LA, Rissman RA, Yaffe K. Association of cardiovascular risk factors and blood biomarkers with cognition: The HABS-HD study. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring [Internet]. 2023 [cited 2024 Apr 30];15:e12394. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/https:\/\/doi.org\/10.1002\/dad2.12394","DOI":"10.1002\/dad2.12394"},{"key":"1731_CR25","doi-asserted-by":"crossref","unstructured":"Pettigrew C, Soldan A, Wang J, Wang MC, Arthur K, Moghekar A et al. Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline. Neurology [Internet]. 2020 [cited 2024 May 1];95:E3093\u2013103. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32989109\/","DOI":"10.1212\/WNL.0000000000010946"},{"key":"1731_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/07448480009596270","volume":"48","author":"G Weidner","year":"2000","unstructured":"Weidner G. Why do men get more heart disease than women?? An international perspective. J Am Coll Health. 2000;48:291\u20134.","journal-title":"J Am Coll Health"},{"key":"1731_CR27","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/j.arr.2010.08.006","volume":"9","author":"C-W Hung","year":"2010","unstructured":"Hung C-W, Chen Y-C, Hsieh W-L, Chiou S-H, Kao C-L. Ageing and neurodegenerative diseases. Ageing Res Rev. 2010;9:S36\u201346.","journal-title":"Ageing Res Rev"},{"key":"1731_CR28","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-016-1547-z","volume":"131","author":"LM Tai","year":"2016","unstructured":"Tai LM, Thomas R, Marottoli FM, Koster KP, Kanekiyo T, Morris AWJ, et al. The role of APOE in cerebrovascular dysfunction. Acta Neuropathol. 2016;131:709\u201323.","journal-title":"Acta Neuropathol"},{"key":"1731_CR29","doi-asserted-by":"publisher","unstructured":"Mahinrad S, Sorond FA, Gorelick PB. Hypertension and cognitive dysfunction: a review of mechanisms, life-course observational studies and clinical trial results. Rev Cardiovasc Med [Internet]. 2021 [cited 2022 Jun 23];22:1429\u201349. Available from: https:\/\/www.imrpress.com\/journal\/RCM\/22\/4\/https:\/\/doi.org\/10.31083\/j.rcm2204148\/htm","DOI":"10.31083\/j.rcm2204148\/htm"},{"key":"1731_CR30","doi-asserted-by":"crossref","unstructured":"Nation DA, Edmonds EC, Bangen KJ, Delano-Wood L, Scanlon BK, Han SD et al. Pulse Pressure in Relation to Tau-Mediated Neurodegeneration, Cerebral Amyloidosis, and Progression to Dementia in Very Old Adults. JAMA Neurol [Internet]. 2015 [cited 2024 Apr 30];72:546\u201353. Available from: https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2212146","DOI":"10.1001\/jamaneurol.2014.4477"},{"key":"1731_CR31","doi-asserted-by":"crossref","unstructured":"Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP et al. Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials. Lancet [Internet]. 2000 [cited 2024 Sep 18];355:865\u201372. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/10752701\/","DOI":"10.1016\/S0140-6736(99)07330-4"},{"key":"1731_CR32","unstructured":"Physiology BP. Age Related Changes - PubMed [Internet]. [cited 2024 May 7]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30725982\/"},{"key":"1731_CR33","doi-asserted-by":"crossref","unstructured":"Chou CH, Yin JH, Lin YK, Yang FC, Chu TW, Chuang YC et al. The optimal pulse pressures for healthy adults with different ages and sexes correlate with cardiovascular health metrics. Front Cardiovasc Med [Internet]. 2022 [cited 2024 May 7];9. Available from: \/pmc\/articles\/PMC9760735\/.","DOI":"10.3389\/fcvm.2022.930443"},{"key":"1731_CR34","doi-asserted-by":"crossref","unstructured":"Wei FF, Wu Y, Xue R, Liu X, He X, Dong B et al. Clinical Significance of Mean and Pulse Pressure in Patients With Heart Failure With Preserved Ejection Fraction. Hypertension [Internet]. 2022 [cited 2024 May 7];79:241\u201350. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34739763\/","DOI":"10.1161\/HYPERTENSIONAHA.121.17782"},{"key":"1731_CR35","unstructured":"Homan TD, Bordes SJ, Cichowski E, Physiology. Pulse Pressure. StatPearls [Internet]. 2023 [cited 2024 May 7]; Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482408\/"},{"key":"1731_CR36","doi-asserted-by":"crossref","unstructured":"Panagiotakos DB, Kromhout D, Menotti A, Chrysohoou C, Dontas A, Pitsavos C et al. The Relation Between Pulse Pressure and Cardiovascular Mortality in 12 763 Middle-aged Men From Various Parts of the World: A 25-Year Follow-up of the Seven Countries Study. Arch Intern Med [Internet]. 2005 [cited 2024 May 7];165:2142\u20137. Available from: https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/486735","DOI":"10.1001\/archinte.165.18.2142"},{"key":"1731_CR37","doi-asserted-by":"crossref","unstructured":"Manouchehrinia A, Piehl F, Hillert J, Kuhle J, Alfredsson L, Olsson T et al. Confounding effect of blood volume and body mass index on blood neurofilament light chain levels. Ann Clin Transl Neurol [Internet]. 2020 [cited 2024 Dec 3];7:139. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6952306\/","DOI":"10.1002\/acn3.50972"},{"key":"1731_CR38","doi-asserted-by":"crossref","unstructured":"Pinto E. Blood pressure and ageing. Postgrad Med J [Internet]. 2007 [cited 2024 Dec 3];83:109. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2805932\/","DOI":"10.1136\/pgmj.2006.048371"},{"key":"1731_CR39","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13195-024-01629-y","volume":"16","author":"G Argiris","year":"2024","unstructured":"Argiris G, Akinci M, Pe\u00f1a-G\u00f3mez C, Palpatzis E, Garcia-Prat M, Shekari M, et al. Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer\u2019s disease. Alzheimers Res Ther. 2024;16:274.","journal-title":"Alzheimers Res Ther"},{"key":"1731_CR40","doi-asserted-by":"publisher","first-page":"e1452","DOI":"10.1212\/WNL.0000000000005354","volume":"90","author":"SM Landau","year":"2018","unstructured":"Landau SM, Horng A, Jagust WJ. Memory decline accompanies subthreshold amyloid accumulation. Neurology. 2018;90:e1452\u201360.","journal-title":"Neurology"},{"key":"1731_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13195-022-01035-2","volume":"14","author":"H-J Kim","year":"2022","unstructured":"Kim H-J, Oh JS, Lim J-S, Lee S, Jo S, Chung E-N, et al. The impact of subthreshold levels of amyloid deposition on conversion to dementia in patients with amyloid-negative amnestic mild cognitive impairment. Alzheimers Res Ther. 2022;14:93.","journal-title":"Alzheimers Res Ther"},{"key":"1731_CR42","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.111.178962","volume":"59","author":"NS Shah","year":"2012","unstructured":"Shah NS, Vidal J-S, Masaki K, Petrovitch H, Ross GW, Tilley C, et al. Midlife blood pressure, plasma \u03b2-Amyloid, and the risk for alzheimer disease. Hypertension. 2012;59:780\u20136.","journal-title":"Hypertension"},{"key":"1731_CR43","doi-asserted-by":"crossref","unstructured":"She M, Shang S, Hu N, Chen C, Dang L, Gao L et al. Blood pressure level is associated with changes in plasma A\u03b21\u2013\u200940 and A\u03b21\u201342 levels: A Cross-sectional study conducted in the suburbs of Xi\u2019an, China. Front Aging Neurosci. 2021;13.","DOI":"10.3389\/fnagi.2021.650679"},{"key":"1731_CR44","doi-asserted-by":"publisher","first-page":"694982","DOI":"10.3389\/fnagi.2021.694982","volume":"13","author":"N Cherbuin","year":"2021","unstructured":"Cherbuin N, Walsh EI, Shaw M, Luders E, Anstey KJ, Sachdev PS, et al. Optimal blood pressure keeps our brains younger. Front Aging Neurosci. 2021;13:694982.","journal-title":"Front Aging Neurosci"},{"key":"1731_CR45","doi-asserted-by":"crossref","unstructured":"Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Ambulatory blood pressure as an independent determinant of brain atrophy and cognitive function in elderly hypertension. J Hypertens [Internet]. 2008 [cited 2024 Dec 3];26:1636\u201341. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18622243\/","DOI":"10.1097\/HJH.0b013e3283018333"},{"key":"1731_CR46","doi-asserted-by":"crossref","unstructured":"Deckers K, Van Boxtel MPJ, Schiepers OJG, De Vugt M, S\u00e1nchez JLM, Anstey KJ et al. Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry [Internet]. 2015 [cited 2024 May 1];30:234\u201346. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25504093\/","DOI":"10.1002\/gps.4245"},{"key":"1731_CR47","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1161\/HYPERTENSIONAHA.121.18799","volume":"79","author":"R Peters","year":"2022","unstructured":"Peters R, Xu Y, Eramudugolla R, Sachdev PS, Cherbuin N, Tully PJ, et al. Diastolic blood pressure variability in later life May be a key risk marker for cognitive decline. Hypertension. 2022;79:1037\u201344.","journal-title":"Hypertension"},{"key":"1731_CR48","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1212\/WNL.0b013e3181b38969","volume":"73","author":"G Tsivgoulis","year":"2009","unstructured":"Tsivgoulis G, Alexandrov AV, Wadley VG, Unverzagt FW, Go RCP, Moy CS, et al. Association of higher diastolic blood pressure levels with cognitive impairment. Neurology. 2009;73:589\u201395.","journal-title":"Neurology"},{"key":"1731_CR49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/107424840100600102","volume":"6","author":"WW Nichols","year":"2001","unstructured":"Nichols WW, Edwards DG. Arterial elastance and wave reflection augmentation of systolic blood pressure: deleterious effects and implications for therapy. J Cardiovasc Pharmacol Ther. 2001;6:5\u201321.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"1731_CR50","doi-asserted-by":"crossref","unstructured":"O\u2019Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante G. e. E. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens. 2002;15:426\u201344.","DOI":"10.1016\/S0895-7061(01)02319-6"},{"key":"1731_CR51","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/01.CIR.96.1.308","volume":"96","author":"SS Franklin","year":"1997","unstructured":"Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of Age-Related changes in blood pressure. Circulation. 1997;96:308\u201315.","journal-title":"Circulation"},{"key":"1731_CR52","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s11906-013-0398-4","volume":"15","author":"D G\u0105secki","year":"2013","unstructured":"G\u0105secki D, Kwarciany M, Nyka W, Narkiewicz K, Hypertension. Brain damage and cognitive decline. Curr Hypertens Rep. 2013;15:547\u201358.","journal-title":"Curr Hypertens Rep"},{"key":"1731_CR53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11906-018-0822-x","volume":"20","author":"A Avolio","year":"2018","unstructured":"Avolio A, Kim MO, Adji A, Gangoda S, Avadhanam B, Tan I, et al. Cerebral haemodynamics: effects of systemic arterial pulsatile function and hypertension. Curr Hypertens Rep. 2018;20:20.","journal-title":"Curr Hypertens Rep"},{"key":"1731_CR54","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jnr.23827","volume":"95","author":"CJ Pike","year":"2017","unstructured":"Pike CJ. Sex and the development of Alzheimer\u2019s disease. J Neurosci Res. 2017;95:671\u201380.","journal-title":"J Neurosci Res"},{"key":"1731_CR55","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","volume":"19","author":"D Singh","year":"2022","unstructured":"Singh D. Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease. J Neuroinflammation. 2022;19:206.","journal-title":"J Neuroinflammation"},{"key":"1731_CR56","doi-asserted-by":"publisher","first-page":"458","DOI":"10.5114\/aoms\/157308","volume":"19","author":"K Ryczkowska","year":"2023","unstructured":"Ryczkowska K, Adach W, Janikowski K, Banach M, Bielecka-Dabrowa A. Menopause and women\u2019s cardiovascular health: is it really an Obvious relationship? Archives Med Sci. 2023;19:458\u201366.","journal-title":"Archives Med Sci"},{"key":"1731_CR57","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu C-C, Bu G. Apolipoprotein E and alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15:501\u201318.","journal-title":"Nat Rev Neurol"},{"key":"1731_CR58","doi-asserted-by":"publisher","first-page":"16288","DOI":"10.3390\/ijms242216288","volume":"24","author":"AE Alkhalifa","year":"2023","unstructured":"Alkhalifa AE, Al-Ghraiybah NF, Odum J, Shunnarah JG, Austin N, Kaddoumi A. Blood\u2013Brain barrier breakdown in Alzheimer\u2019s disease: mechanisms and targeted strategies. Int J Mol Sci. 2023;24:16288.","journal-title":"Int J Mol Sci"},{"key":"1731_CR59","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","volume":"78","author":"S Janelidze","year":"2021","unstructured":"Janelidze S, Teunissen CE, Zetterberg H, Allu\u00e9 JA, Sarasa L, Eichenlaub U, et al. Head-to-Head comparison of 8 plasma Amyloid-\u03b2 42\/40 assays in alzheimer disease. JAMA Neurol. 2021;78:1375.","journal-title":"JAMA Neurol"},{"key":"1731_CR60","doi-asserted-by":"publisher","first-page":"105504","DOI":"10.1016\/j.ebiom.2024.105504","volume":"112","author":"M Bluma","year":"2025","unstructured":"Bluma M, Chiotis K, Bucci M, Savitcheva I, Matton A, Kivipelto M, et al. Disentangling relationships between Alzheimer\u2019s disease plasma biomarkers and established biomarkers in patients of tertiary memory clinics. EBioMedicine. 2025;112:105504.","journal-title":"EBioMedicine"},{"key":"1731_CR61","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jamaneurol.2023.0199","volume":"80","author":"S Janelidze","year":"2023","unstructured":"Janelidze S, Barth\u00e9lemy NR, He Y, Bateman RJ, Hansson O, Authors C. Mitigating the associations of kidney dysfunction with blood biomarkers of alzheimer disease by using phosphorylated Tau to total Tau ratios supplemental content. JAMA Neurol. 2023;80:516\u201322.","journal-title":"JAMA Neurol"},{"key":"1731_CR62","doi-asserted-by":"crossref","unstructured":"Berry K, Asken BM, Grab JD, Chan B, Lario Lago A, Wong R et al. Hepatic and renal function impact concentrations of plasma biomarkers of neuropathology. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring [Internet]. 2022 [cited 2025 Mar 19];14:e12321. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9274803\/","DOI":"10.1002\/dad2.12321"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01731-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01731-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01731-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T04:23:44Z","timestamp":1745209424000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01731-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1731"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01731-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6018137\/v1","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board of the University of California, San Francisco and is conducted in accordance with the latest Declaration of Helsinki Manuscripts, including written informed consent from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JHK receives royalties from Pearson\u2019s Inc. JCR is a site principal investigator for clinical trials sponsored by Eli-Lilly, Eisai and Amylyx. The authors report no other conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}